NCT03862950View on ClinicalTrials.gov

A Trial of Metformin in Individuals With Fragile X Syndrome (Met)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

May 24, 2019

Primary Completion Date

December 8, 2025

Study Completion Date

December 8, 2025

Conditions
Fragile X SyndromeFragile X Mental Retardation SyndromeMental Retardation, X-LinkedGenetic Diseases, X-LinkedTrinucleotide Repeat ExpansionFra(X) SyndromeIntellectual DisabilityFXSNeurobehavioral ManifestationsSex Chromosome Disorders
Interventions
DRUG

Placebo Medication

Placebo liquid or capsules given in parallel to active medication.

DRUG

Metformin

Active medication

Trial Locations (2)

T6G 2E1

University of Alberta, Edmonton

H3T 1C5

CHU Sainte-Justine, Montreal

All Listed Sponsors
collaborator

St. Justine's Hospital

OTHER

lead

University of Alberta

OTHER